BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corcoran JP, Wrightson JM, Belcher E, DeCamp MM, Feller-Kopman D, Rahman NM. Pleural infection: past, present, and future directions. Lancet Respir Med 2015;3:563-77. [PMID: 26170076 DOI: 10.1016/S2213-2600(15)00185-X] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Kanellakis NI, Wrightson JM, Gerry S, Ilott N, Corcoran JP, Bedawi EO, Asciak R, Nezhentsev A, Sundaralingam A, Hallifax RJ, Economides GM, Bland LR, Daly E, Yao X, Maskell NA, Miller RF, Crook DW, Hinks TSC, Dong T, Psallidas I, Rahman NM. The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing. The Lancet Microbe 2022. [DOI: 10.1016/s2666-5247(21)00327-x] [Reference Citation Analysis]
2 Yang CY, Kuo YH, Chen M, Wang CL, Shih LJ, Liu YC, Hsueh PC, Lai YH, Chu CM, Wu CC, Wu KA. Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema. Sci Rep 2021;11:1763. [PMID: 33469074 DOI: 10.1038/s41598-021-81053-6] [Reference Citation Analysis]
3 Tamburrini S, Lugarà M, Saturnino PP, Ferrandino G, Quassone P, Leboffe S, Sarti G, Rocco C, Panico C, Raffaele F, Cesarano T, Iannuzzi M, Cagini L, Marano I. Pleural empyema secondary to nephropleural fistula in complicated pyonephrosis. Radiol Case Rep 2021;16:2714-8. [PMID: 34336076 DOI: 10.1016/j.radcr.2021.06.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sundaralingam A, Banka R, Rahman NM. Management of Pleural Infection. Pulm Ther 2021;7:59-74. [PMID: 33296057 DOI: 10.1007/s41030-020-00140-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Gorman J, Funk D, Srinathan S, Embil J, Girling L, Kowalski S. Perioperative implications of thoracic decortications: a retrospective cohort study. Can J Anaesth 2017;64:845-53. [PMID: 28493038 DOI: 10.1007/s12630-017-0896-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
6 Corcoran JP, Hallifax RJ, Psallidas I, Rahman NM. Pleural Diseases: Saline Irrigation in Pleural Infection, Epidemiology of Pneumothorax, and Bevacizumab in Mesothelioma. Am J Respir Crit Care Med 2017;196:382-5. [PMID: 28598211 DOI: 10.1164/rccm.201608-1676RR] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Akulian J, Feller-Kopman D. The past, current and future of diagnosis and management of pleural disease. J Thorac Dis 2015;7:S329-38. [PMID: 26807281 DOI: 10.3978/j.issn.2072-1439.2015.11.52] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Arnold DT, Hamilton FW, Elvers KT, Frankland SW, Zahan-Evans N, Patole S, Medford A, Bhatnagar R, Maskell NA. Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions. Am J Respir Crit Care Med 2020;201:1545-53. [PMID: 32069085 DOI: 10.1164/rccm.201911-2169OC] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
9 Piracha S, Ahmed SSM, Mohd Afzal S, Ganaie MB. Empyema thoracis secondary to community-acquired Panton-Valentine leukocidin (PVL) methicillin-resistant Staphylococcus aureus (MRSA) infection. BMJ Case Rep 2019;12:e228297. [PMID: 30948401 DOI: 10.1136/bcr-2018-228297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Kanellakis NI, Wrightson JM, Hallifax R, Bedawi EO, Mercer R, Hassan M, Asciak R, Hedley E, Dobson M, Dong T, Psallidas I, Rahman NM. Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients. BMJ Open Respir Res 2019;6:e000440. [PMID: 31673364 DOI: 10.1136/bmjresp-2019-000440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl SC, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Schwartzman JD, Snyder JW, Telford S 3rd, Theel ES, Thomson RB Jr, Weinstein MP, Yao JD. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018;67:e1-e94. [PMID: 29955859 DOI: 10.1093/cid/ciy381] [Cited by in Crossref: 131] [Cited by in F6Publishing: 98] [Article Influence: 43.7] [Reference Citation Analysis]
12 Badiei A, Chan KP, Lee YCG, Waterer GW. Corticosteroids in Lung and Pleural Infections. Curr Pulmonol Rep 2018;7:19-27. [DOI: 10.1007/s13665-018-0197-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Wu KA, Wu CC, Chen CD, Chu CM, Shih LJ, Liu YC, Wang CL, Lin HH, Yang CY. Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions. Sci Rep 2017;7:4026. [PMID: 28642494 DOI: 10.1038/s41598-017-04189-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Chatziparasidis G, Kantar A. Calprotectin: An Ignored Biomarker of Neutrophilia in Pediatric Respiratory Diseases. Children (Basel) 2021;8:428. [PMID: 34063831 DOI: 10.3390/children8060428] [Reference Citation Analysis]
15 Varsamas C, Kalkanis A, Gourgoulianis KI, Malli F. The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions. Can Respir J 2020;2020:1283590. [PMID: 33082889 DOI: 10.1155/2020/1283590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Porcel J, Valencia H, Bielsa S. Adult patients with parapneumonic empyema who may not require pleural drainage. Revista Clínica Española 2016;216:172-4. [DOI: 10.1016/j.rce.2016.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Bhatnagar R, Skouras VS, Rahman NM, Psallidas I. Antibiotics for pleural infections. In: Aliberti S, Chalmers JD, Pletz MW, editors. Anti-infectives and the Lung. European Respiratory Society; 2017. pp. 253-63. [DOI: 10.1183/2312508x.10005816] [Cited by in Crossref: 2] [Reference Citation Analysis]
18 Hassan M, Daneshvar C, Corcoran JP. Pleural Infection—a Growing Problem in the Elderly. Curr Geri Rep 2020;9:47-53. [DOI: 10.1007/s13670-020-00320-y] [Reference Citation Analysis]
19 Mondoni M, Saderi L, Trogu F, Terraneo S, Carlucci P, Ghelma F, Centanni S, Sotgiu G. Medical thoracoscopy treatment for pleural infections: a systematic review and meta-analysis. BMC Pulm Med 2021;21:127. [PMID: 33879116 DOI: 10.1186/s12890-021-01492-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Addala DN, Bedawi EO, Rahman NM. Parapneumonic Effusion and Empyema. Clin Chest Med 2021;42:637-47. [PMID: 34774171 DOI: 10.1016/j.ccm.2021.08.001] [Reference Citation Analysis]
21 Gilbert CR, Gorden JA. Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens. Curr Opin Pulm Med 2017;23:371-5. [PMID: 28399008 DOI: 10.1097/MCP.0000000000000387] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Wu KA, Wu CC, Liu YC, Hsueh PC, Chin CY, Wang CL, Chu CM, Shih LJ, Yang CY. Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema. BMC Pulm Med 2019;19:108. [PMID: 31215423 DOI: 10.1186/s12890-019-0877-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
23 Lee YJ, Lee J, Kwon BS, Kim Y. An empyema caused by Streptococcus constellatus in an older immunocompetent patient: Case report. Medicine (Baltimore) 2021;100:e27893. [PMID: 34766602 DOI: 10.1097/MD.0000000000027893] [Reference Citation Analysis]
24 Mercer RM, Corcoran JP, Porcel JM, Rahman NM, Psallidas I. Interpreting pleural fluid results . Clin Med (Lond) 2019;19:213-7. [PMID: 31092513 DOI: 10.7861/clinmedicine.19-3-213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
25 Hassan M, Patel S, Sadaka AS, Bedawi EO, Corcoran JP, Porcel JM. Recent Insights into the Management of Pleural Infection. Int J Gen Med 2021;14:3415-29. [PMID: 34290522 DOI: 10.2147/IJGM.S292705] [Reference Citation Analysis]
26 Zhou F, Sun S, Sun X, Chen Y, Yang X. Rapid and sensitive identification of pleural and peritoneal infections by droplet digital PCR. Folia Microbiol (Praha) 2021;66:213-9. [PMID: 33159654 DOI: 10.1007/s12223-020-00834-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Iliopoulou M, Skouras V, Psaroudaki Z, Makarona M, Vogiatzakis E, Tsorlini E, Katsifa E, Spyratos D, Siopi D, Kotsiou O, Xitsas S, Martsoukou M, Sigala I, Kalomenidis I. Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infection. J Thorac Dis 2021;13:521-32. [PMID: 33717525 DOI: 10.21037/jtd-20-2786] [Reference Citation Analysis]
28 Touray S, Sood RN, Lindstrom D, Holdorf J, Ahmad S, Knox DB, Sosa AF. Risk Stratification in Patients with Complicated Parapneumonic Effusions and Empyema Using the RAPID Score. Lung 2018;196:623-9. [PMID: 30099584 DOI: 10.1007/s00408-018-0146-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]